Literature DB >> 7608458

Diagnosis and management of fetal cardiac tumors: a multicenter experience and review of published reports.

D G Holley1, G R Martin, J I Brenner, D A Fyfe, J C Huhta, C S Kleinman, S B Ritter, N H Silverman.   

Abstract

OBJECTIVES: We sought to determine the prevalence and natural history of cardiac tumors in patients referred for fetal echocardiography.
BACKGROUND: Cardiac tumors are rare; the prevalence, reported from autopsy studies of patients of all ages, varies from 0.0017% to 0.28%. Despite many case reports, the prevalence and natural history of fetal cardiac tumors are unclear.
METHODS: Fourteen thousand fetal echocardiograms recorded over an 8-year period in seven centers were available for retrospective review. Medical records and echocardiograms were studied to determine the reason for referral, family history of tuberous sclerosis, prenatal and postnatal course and tumor description and type.
RESULTS: Cardiac tumors were present in 19 pregnancies (0.14%). Gestational age at diagnosis ranged from 21 to 38 weeks. The most common indication for referral was a mass on an obstetric ultrasound study. The tumors were singular in 10 patients and multiple in 9. Tumor size ranged from 0.4 x 0.4 to 3.5 x 4 cm, and the majority of tumors were not hemodynamically significant. There were 17 patients with rhabdomyomas, 1 with a fibroma and 1 with an atrial hemangioma. Tuberous sclerosis complex was diagnosed in 10 patients. Partial or complete tumor regression was seen in eight patients; tumors were unchanged in five; and three required operation.
CONCLUSIONS: Fetal cardiac tumors, a rare condition, are often benign. The majority of tumors are rhabdomyomas, but not all fetuses with rhabdomyoma have tuberous sclerosis.

Entities:  

Mesh:

Year:  1995        PMID: 7608458     DOI: 10.1016/0735-1097(95)80031-b

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  47 in total

Review 1.  Evolution of heart disease in utero.

Authors:  J Trines; L K Hornberger
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

2.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

3.  Uncommon antenatal presentation of tuberous sclerosis.

Authors:  Eleni Paleologou; Richard Nicholl
Journal:  BMJ Case Rep       Date:  2014-06-23

4.  Prenatal diagnosis of giant cardiac rhabdomyoma with fetal hydrops in tuberous sclerosis.

Authors:  Frederike Schlaegel; Zoltan Takacs; Erich Franz Solomayer; Hashim Abdul-Kaliq; Gabriele Meyberg-Solomayer
Journal:  J Prenat Med       Date:  2013-07

5.  Giant left atrial myxoma causing severe pulmonary hypertension.

Authors:  Reiko Mizuno; Yoshiyuki Hayata; Shigeki Taniguchi; Yoshihiko Saito; Yasuyuki Okamoto; Shinichi Fujimoto
Journal:  J Echocardiogr       Date:  2011-06-23

6.  Imitation of a chronic recurrent inflammatory illness by a cardiac myxoma.

Authors:  J P Pfammatter; T Iff; P Schüpbach
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

Review 7.  Diagnosis and management of heart failure in the fetus.

Authors:  B Davey; A Szwast; J Rychik
Journal:  Minerva Pediatr       Date:  2012-10       Impact factor: 1.312

8.  Cardiac tumors in infants and children: study of 120 operated patients.

Authors:  Kyle J Bielefeld; James H Moller
Journal:  Pediatr Cardiol       Date:  2012-06-27       Impact factor: 1.655

9.  Cardiac rhabdomyomas associated with tuberous sclerosis complex in children. From presentation to outcome.

Authors:  Q Shen; J Shen; Z Qiao; Q Yao; G Huang; X Hu
Journal:  Herz       Date:  2014-03-09       Impact factor: 1.443

Review 10.  Prenatal ultrasound findings of fetal neoplasms.

Authors:  Soo Hyun Lee; Jeong Yeon Cho; Mi Jin Song; Jee Yeon Min; Byoung Hee Han; Young Ho Lee; Byung Jae Cho; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2002 Jan-Mar       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.